June 1, 2017 5:46pm

 

New month and closer to the end of Q2

May was a toxic to the sector as momentum drives “our” universe

 

Pre-open indications: 5 hits and 1 miss

 

I tick some CEOs off. As the leading voice of cell therapy “investors”; I am about the “facts in evidence” and not a doom or gloom reporter but a man who has been “there” with the gray hair to prove it and a following with real numbers!

 

I answer one question, in which company should investors commit and keep their money.

 

 


 

RMi’s daily and continual “reads” of the goings-on of the SCG&RT sector can improve investor’s and trader’s odds - just because a stock underperforms the market doesn’t mean you have to lose money.

 

 

Henry’omics:

From the pre-open’s investor’s newsletter … “The word the sector grapples with is trust. Where is the proof of life?”

  • Reiterating, “Is there a certificate that shows appreciation in “our” universe could still be alive? … I’m willing to negotiate with the algorithms and ETFs for the release of the sector in a new month.”

All three main stock indexes closed at records Thursday as a strong read on private-sector employment helped to bolster confidence in the economy ahead of Friday’s closely watched jobs report.

 

What a rebound from Monday, Tuesday and Wednesday …

The cell therapy sector’s advance/decline record after the last 4 days (of 43 covered companies):

·         Thursday closed POSITIVE with 10 decliners, 29 advancers and 4 flats;

·         Wednesday closed NEGATIVE with 24 decliners, 14 advancers and 5 flats;

·         Tuesday closed NEGATIVE with 29 decliners, 10 advancers and 4 flat;

·         Monday was Memorial Day and the U.S. markets were closed;

 

Volatility is "our" universe's middle name … and volumes are still low except in few companies.

Where was the largest pricing moves: gene therapy and immuno-oncology companies.

 

 

Pre-open indications:  5 hit and 1 miss

  • Bellicum Pharmaceuticals (BLCM) closed up +$0.34 – miss;
  • Biostage (BSTG) closed flat at $0.00 – hit;
  • bluebird bio (BLUE) closed up +$3.85 – hit;
  • Cytori (CYTX) closed up +$0.02 – hit;
  • Mesoblast (MESO) closed down -$0.15 – hit;
  • Neuralstem (CUR) closed up +$0.75 – hit;

 

 

Daily analytics:

U.S. equities closed UP on Thursday … with the DOW closing UP +0.58% (+121.98) as the NASDAQ also closed UP +0.78% (+48.31) …

… The CBOE Volatility Index (VIX) widely considered the best gauge of fear in the market, traded below 10 …

·Wednesday near 10.8,Tuesday traded near 10.2, Friday traded near 9.8 and last  Thursday’s near 9.4,

 

Welcome to another day of the sector’s roller coaster …

… The iShares Russell 2000 (IWM) indicated a negative -0.02% at the pre-open and traded UP +1.93% …

·         Wednesday traded DOWN -0.10%

·         Tuesday traded  -0.77%

·         Monday was a holiday,

·         Friday DOWN -0.03%,

·         Last Thursday’s +0.07,

… The iShares NASDAQ Biotechnology (IBB) indicated a positive +0.45% in the pre-open and traded UP +1.80% …

·         Wednesday  traded UP +0.51%

·         Tuesday DOWN -1.36%

·         Monday was a holiday,

·         Friday DOWN -0.79%,

·         Last Thursday’s -0.22%,

 

 

The advance/decline line scenario of 43 SCGT & RT covered companies:   

·         The open was positive with an A/DL of 28/11 and 4 flats;

·         The mid-day was positive with an A/DL of 35/15 and 3 flats;

·         The close was positive with an A/DL of 29/10 and 4  flats;

 

 

The count - decliners versus gainers: look at the differences in the spreads:

·         Thursday’s decliners ranged from -0.18% <QURE> to -3.17% <VTGN> in 10 equities;

·         Wednesday’s decliners ranged from -0.08% <KITE> to -15.24% <NWBO> in 24 equities;

·         Tuesday’s decliners ranged from -0.37% <XON> to -7.22% <RGNX> in 29 equities;

·         Monday was a holiday;

·         Last Thursday’s decliners ranged from -0.55% <CLLS> to -8.46% <MESO> in 24 equities;

Versus

·         Thursday’s gainers ranged from +0.66% <MDXG> to +18.18% <ISCO> in 29 equities;

·         Wednesday’s gainers ranged from +0.18% <QURE> to +4.94% <CUR> in 14 equities;

·         Tuesday’s gainers ranged from +0.04% <CLLS> to +14.86% <NWBO> in 10 equities;

·         Monday, the market was closed;

·         Friday’s gainers ranged from +0.25% <BSTG> to +5.63% <VCEL> in 11 equities;

·         Last Thursday’s gainers ranged from +0.06% <BLUE> to +4.79% <CAPR> in 17 equities;

 

 

Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.  All investments are subject to risks. Investors should consider investment objectives.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.